{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:21:39Z","timestamp":1791721299888,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T00:00:00Z","timestamp":1664064000000},"content-version":"vor","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.cbi.2021.109675","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T04:55:15Z","timestamp":1632459315000},"page":"109675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The toxicity of 1,3,4-thiadiazolium mesoionic derivatives on hepatocarcinoma cells (HepG2) is associated with mitochondrial dysfunction"],"prefix":"10.1016","volume":"349","author":[{"given":"Rafaela Aparecida","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7619-904X","authenticated-orcid":false,"given":"Amanda do Rocio Andrade","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurea","family":"Echevarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Sousa-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilhermina Rodrigues","family":"Noleto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Maria","family":"Suter Correia Cadena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2021.109675_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA. Canc. J. Clin."},{"key":"10.1016\/j.cbi.2021.109675_bib2","first-page":"1","article-title":"Epidemiology of Hepatocellular Carcinoma Hepatitis","volume":"24","author":"Lafaro","year":"2015","journal-title":"C Incidence Risk factors Aflatoxin"},{"key":"10.1016\/j.cbi.2021.109675_bib3","series-title":"Randomized Clinical Trial of Hepatic Resection versus Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma","first-page":"1775","author":"Ng","year":"2017"},{"key":"10.1016\/j.cbi.2021.109675_bib4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Clinical practice guidelines OF HEPATOLOGY EASL clinical practice Guidelines\u00a0: management of hepatocellular carcinoma q","volume":"69","author":"Galle","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2021.109675_bib5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.surg.2017.12.005","article-title":"Liver transplant offers a survival benefit over margin negative resection in patients with small unifocal hepatocellular carcinoma and preserved liver function","volume":"163","author":"Benjamin","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.cbi.2021.109675_bib6","first-page":"837","article-title":"Prevention and management of adverse events related to regorafenib","volume":"22","author":"De Wit","year":"2014","journal-title":"Support. Care Canc."},{"key":"10.1016\/j.cbi.2021.109675_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2019.04.021","article-title":"Risk of hand-foot skin reaction associated with vascular endothelial growth factor\u2013tyrosine kinase inhibitors: a meta-analysis of 57 randomized controlled trials involving 24,956 patients","author":"Ding","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cbi.2021.109675_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ctrv.2019.05.004","article-title":"Management of adverse events associated with tyrosine kinase inhibitors\u00a0: improving outcomes for patients with hepatocellular carcinoma","volume":"77","author":"Rimassa","year":"2019","journal-title":"Canc. Treat Rev."},{"key":"10.1016\/j.cbi.2021.109675_bib9","unstructured":"L. Kulik, H.B. El-Serag, Epidemiology and Management of Hepatocellular Carcinoma, (n.d.). https:\/\/doi.org\/10.1053\/j.gastro.2018.08.065.."},{"key":"10.1016\/j.cbi.2021.109675_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00001813-199701000-00012","article-title":"Synthesis and in vivo antitumor activity of new heterocyclic derivatives of the 1,3,4-thiadiazolium-2-aminide class","volume":"8","author":"Grynberg N","year":"1997","journal-title":"Anti Canc. Drugs"},{"key":"10.1016\/j.cbi.2021.109675_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00001813-200403000-00012","article-title":"Antimelanoma activity of 1,3,4-thiadiazolium mesoionics: a structure-activity relationship study","volume":"15","author":"Senff-Ribeiro","year":"2004","journal-title":"Anti Canc. Drugs"},{"key":"10.1016\/j.cbi.2021.109675_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00008390-200310000-00005","article-title":"Effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on B16-F10 murine melanoma","volume":"13","author":"Senff-Ribeiro","year":"2003","journal-title":"Melanoma Res."},{"key":"10.1016\/j.cbi.2021.109675_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/sj.bjc.6601946","article-title":"Cytotoxic effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on cell lines of human melanoma","volume":"91","author":"Senff-Ribeiro","year":"2004","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.cbi.2021.109675_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.932","article-title":"Interference of MI-D, a new mesoionic compound, on artificial and native membranes","author":"Cadena","year":"2002","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.cbi.2021.109675_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0014-5793(98)01427-6","article-title":"Effect of MI-D, a new mesoionic compound, on energy-linked functions of rat liver mitochondria","volume":"440","author":"Cadena","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cbi.2021.109675_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2010.04.001","article-title":"Comparative study of the effects of 1,3,4-thiadiazolium mesoionic derivatives on energy-linked functions of rat liver mitochondria","volume":"186","author":"Pires","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2021.109675_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2015.12.004","article-title":"Antioxidant effect of 1,3,4-thiadiazolium mesoionic derivatives on isolated mitochondria","volume":"770","author":"Pires","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109675_bib18","first-page":"1","article-title":"Targeting mitochondria as an anticancer strategy","author":"Dong","year":"2019","journal-title":"Canc. Commun."},{"key":"10.1016\/j.cbi.2021.109675_bib19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bbrc.2016.11.088","article-title":"Biochemical and Biophysical Research Communications the role of mitochondria in metabolism and cell death","volume":"482","author":"Vakifahmetoglu-norberg","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2021.109675_bib20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/toxsci\/kfm052","article-title":"Circumventing the crabtree effect: replacing media glucose with galactose increases susceptibility of hepG2 cells to mitochondrial toxicants","volume":"97","author":"Marroquin","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2021.109675_bib21","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.3390\/ijms13021933","article-title":"Glucose-modulated mitochondria adaptation in tumor cells: a focus on ATP synthase and Inhibitor Factor 1","volume":"13","author":"Domenis","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2021.109675_bib22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/mrc.812","article-title":"Electronic effects on13C NMR chemical shifts of substituted 1,3,4-thiadiazolium salts","volume":"39","author":"Dos Santos","year":"2001","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.cbi.2021.109675_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cbi.2021.109675_bib24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0887-2333(89)90039-8","article-title":"Cytotoxicity test with simplified crystal violet staining method using microtitre plates and its application to injection drugs","volume":"3","author":"Saotome","year":"1989","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.cbi.2021.109675_bib25","series-title":"Dye Exclusion Tests for Cell Viability","first-page":"406","author":"Phillips","year":"1973"},{"key":"10.1016\/j.cbi.2021.109675_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.exger.2005.09.011","article-title":"High-resolution respirometry-a modern tool in aging research","volume":"41","author":"H\u00fctter","year":"2006","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.cbi.2021.109675_bib27","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.biocel.2009.03.013","article-title":"Capacity of oxidative phosphorylation in human skeletal muscle. New perspectives of mitochondrial physiology","volume":"41","author":"Gnaiger","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cbi.2021.109675_bib28","first-page":"1446","article-title":"Pyruvate, phosphoenolpyruvate and D-glycerate-2-phosphate (UV-method)","volume":"3","author":"Czoc","year":"1974","journal-title":"Methods Enzym. Anal."},{"key":"10.1016\/j.cbi.2021.109675_bib29","first-page":"1464","article-title":"D-(+)-Lactate determination with lactate dehydrogenase and NAD","author":"Gutmann","year":"1974","journal-title":"Methods Enzym. Anal."},{"key":"10.1016\/j.cbi.2021.109675_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cbi.2021.109675_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2016.07.007","article-title":"Impairment of oxidative phosphorylation increases the toxicity of SYD-1 on hepatocarcinoma cells (HepG2)","author":"Brandt","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2021.109675_bib32","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-03-1101","article-title":"Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells","author":"Rossignol","year":"2004","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2021.109675_bib33","article-title":"The Warburg effect: how does it benefit cancer cells?","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cbi.2021.109675_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/onc.2009.358","article-title":"Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer","author":"Deberardinis","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2021.109675_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cbf.932","article-title":"Interference of MI-D, a new mesoionic compound, on artificial and native membranes","volume":"20","author":"Cadena","year":"2002","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.cbi.2021.109675_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0022-1759(83)90438-6","article-title":"An enzyme-release assay for natural cytotoxicity","volume":"64","author":"Korzeniewski C","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cbi.2021.109675_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cbi.2010.09.030","article-title":"Interaction of 1,3,4-thiadiazolium mesoionic derivatives with mitochondrial membrane and scavenging activity: involvement of their effects on mitochondrial energy-linked functions","volume":"189","author":"Pires","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2021.109675_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0130046","article-title":"Selective cytotoxicity of 1,3,4-thiadiazolium mesoionic derivatives on hepatocarcinoma cells (HepG2)","volume":"10","author":"Gozzi","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.cbi.2021.109675_bib39","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/S0960-894X(03)00487-6","article-title":"Synthesis and biological evaluation of a novel phenyl substituted sydnone series as potential antitumor agents","volume":"13","author":"Dunkley","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2021.109675_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2007.06.003","article-title":"Effect of sydnone SYD-1, energy-linked functions a mesoionic compound, on of rat liver mitochondria","author":"Halila","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2021.109675_bib41","series-title":"Introd. To Biochem. Toxicol.","first-page":"345","article-title":"Effects of toxicants on oxidative phosphorylation and photophosphorylation","author":"Moreland","year":"1994"},{"key":"10.1016\/j.cbi.2021.109675_bib42","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1073\/pnas.0709747104","article-title":"Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis","volume":"104","author":"DeBerardinis","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721003136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721003136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:05:36Z","timestamp":1757858736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279721003136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":42,"alternative-id":["S0009279721003136"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109675","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The toxicity of 1,3,4-thiadiazolium mesoionic derivatives on hepatocarcinoma cells (HepG2) is associated with mitochondrial dysfunction","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109675"}}